Associate Professor, Monash Institute of Pharmaceutical Sciences
| Role | Organisation | Sources |
|---|---|---|
| Associate Professor | Monash Institute of Pharmaceutical Sciences | @AuManufacturing, Brandon Capital portfolio (Tue 3 May 2022), Brandon BioCatalyst portfolio (Tue 3 May 2022), Brandon Capital portfolio (Fri 14 May 2021), Brandon BioCatalyst portfolio (Fri 14 May 2021) |
| Associate Professor | Monash University | Startup Daily |
| CEO and Research Director · Founder | Ankere Therapeutics | @AuManufacturing, Brandon Capital portfolio, Brandon BioCatalyst portfolio, Startup Daily |
Stories naming Professor Bernard Flynn. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of Australian manufacturing items: Manildra draws on CEFC money to quit coal, Ankere Therapeutics launches with seed backing, Micro-X gear reaches Ukraine, plus a vessel naming, precinct tenders, an FFI appointment and a cable rebrand.
Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.
Also Brandon Capital portfolio·Startup Daily·@AuManufacturing